News

C&R Research, a domestic contract research organization (CRO), received the highest score ever, breaking existing records in major items of…

C&R Research announced on the 25th that it has decided to submit a Phase 2 Pre-IND (pre-meeting) application to the…

C&R Research announced on the 18th that it has decided to conduct a global clinical trial with Shaperon and InHandPlus.…

[Newsprime] C&R Research (359090), Korea's first commissioned clinical trial (CRO) company, conducted strategic work for joint academic research and technological…

Vision for Korea’s ‘No. 1’ CRO company Established a local branch and received project orders Standardize your data with your…

C&R Research, a clinical trial consignment agency, achieved its highest performance since listing. C&R Research announced on the 14th that…

  C&R Research, Korea's first contract research organization (CRO) company, supports the development of treatments for rare and incurable diseases…

C&R Research (359090) (CEO Moon-Tae Yoon), Korea's largest clinical trial consignment agency, is carrying out 'data standardization and application tasks…

“For a domestic blockbuster new drug to be created, domestic contract research organizations (CROs) must first secure global-level capabilities. This…

Expert opinions were presented that close cooperation between various fields of expertise, including companies, regulatory agencies, and CROs (drug development…